SANGAMO THERAPEUTICS, INC
Developing genomic cures for severe genetic diseases using proprietary zinc finger technology.
SGMO | NDAQ
Overview
Corporate Details
- ISIN(s):
- US8006771062
- LEI:
- Country:
- United States of America
- Address:
- 501 CANAL BLVD., 94084 RICHMOND
- Website:
- https://www.sangamo.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Sangamo Therapeutics, Inc. is a clinical-stage genomic medicine company focused on translating groundbreaking science into transformative medicines. The company utilizes its proprietary zinc finger technology platform to develop potential genomic cures for patients suffering from severe diseases where current options only manage symptoms. Sangamo's research and development efforts are centered on gene therapy, cell therapy, in vivo genome editing, and gene regulation. The company's pipeline targets a range of genetic disorders, including hemophilia and Fabry disease, and it has engaged in collaborations with partners like Pfizer to advance its therapeutic programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all SANGAMO THERAPEUTICS, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for SANGAMO THERAPEUTICS, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SANGAMO THERAPEUTICS, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
